Unknown

Dataset Information

0

TKI discontinuation in CML: how do we make more patients eligible? How do we increase the chances of a successful treatment-free remission?


ABSTRACT: Treatment-free remission (TFR) is a new and significant goal of chronic myeloid leukemia management. TFR should be considered for patients in stable deep molecular response (DMR) after careful discussion in the shared decision-making process. Second-generation tyrosine kinase inhibitors (TKIs) improve the speed of response and the incidence of DMR. Treatment may be changed to a more active TKI to improve the depth of response in selected patients who have not reached DMR. Stem cell persistence is associated with active immune surveillance and activation of BCR-ABL1-independent pathways, eg, STAT3, JAK1/2, and BCL2. Ongoing studies aim to prove the efficacy of maintenance therapies targeting these pathways after TKI discontinuation.

SUBMITTER: Hochhaus A 

PROVIDER: S-EPMC8791110 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

TKI discontinuation in CML: how do we make more patients eligible? How do we increase the chances of a successful treatment-free remission?

Hochhaus Andreas A   Ernst Thomas T  

Hematology. American Society of Hematology. Education Program 20211201 1


Treatment-free remission (TFR) is a new and significant goal of chronic myeloid leukemia management. TFR should be considered for patients in stable deep molecular response (DMR) after careful discussion in the shared decision-making process. Second-generation tyrosine kinase inhibitors (TKIs) improve the speed of response and the incidence of DMR. Treatment may be changed to a more active TKI to improve the depth of response in selected patients who have not reached DMR. Stem cell persistence i  ...[more]

Similar Datasets

| S-EPMC10062417 | biostudies-literature
| S-EPMC10148988 | biostudies-literature
| S-EPMC6647386 | biostudies-literature
| S-EPMC8038300 | biostudies-literature
| S-EPMC10997502 | biostudies-literature
2020-12-19 | GSE163527 | GEO
2018-01-20 | E-MTAB-2594 | biostudies-arrayexpress